Results 231 to 240 of about 70,973 (282)

SGK1 signaling: an important modulator of CFTR function and early immune response in mouse intestine. [PDF]

Am J Physiol Gastrointest Liver Physiol
Muiler C, Santos A, Ameen NA.
europepmc   +1 more source

Unresolved mechanisms: a hypothesized spatial regulation of myosin light chain phosphorylation within the walls of resistance arteries. [PDF]

Front Physiol
Sun Z, Hill MA.
europepmc   +1 more source

Protective Effect of Paeoniae Radix Alba Carbonisata on Hepatic Amyloidosis by Regulating Calcium Homeostasis. [PDF]

Int J Mol Sci
Liu G, Wang Z, Xu H, Jia J, Xue Z, Ge W, Ji X, Cui L, Huang Y.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase

Cellular Signalling, 2002
The structure of cyclic GMP (cGMP)-binding (cGB), cGMP specific phosphodiesterase (PDE5) comprises several domains. We have used RT-PCR methods to clone the noncatalytic cGB domains of PDE5 from human colon cancer cell RNA and constructed glutathione-S-transferase (GST) fusion proteins to express and study the domains.
Rifat Pamukçu, W Joseph Thompson, W Joseph Thompson   +2 more
exaly   +3 more sources

A primer for measuring cGMP signaling and cGMP-mediated vascular relaxation

Nitric Oxide, 2021
Soluble guanylyl cyclase (sGC, also called GC1) is the main receptor for nitric oxide (NO) that catalyzes the production of the second messenger molecule, 3'5' cyclic guanosine monophosphate (cGMP) leading to vasorelaxation, and inhibition of leukocyte recruitment and platelet aggregation.
Adam C. Straub, Annie Beuve
openaire   +2 more sources

Allosteric Activation of cGMP-Specific, cGMP-Binding Phosphodiesterase (PDE5) by cGMP

Biochemistry, 2002
The effects of cGMP binding on the catalytic activity of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) are unclear because cGMP interacts with both allosteric and catalytic sites specifically. We studied the effects of cGMP on the hydrolysis of a fluorescent substrate analogue, 2'-O-anthraniloyl cGMP, by PDE5 partially purified from rat ...
Daisuke, Okada, Shigeki, Asakawa
openaire   +2 more sources

cGMP in the Vasculature

2009
Cyclic guanosine 3', 5'-monophosphate (cGMP) plays an integral role in the control of vascular function. Generated from guanylate cyclases in response to the endogenous ligands, nitric oxide (NO) and natriuretic peptides (NPs), cGMP influences a number of vascular cell types and regulates vasomotor tone, endothelial permeability, cell growth and ...
Barbara, Kemp-Harper, Harald H H W, Schmidt   +1 more
openaire   +2 more sources

Regulation of metabolism by cGMP

Pharmacology & Therapeutics, 2013
The second messenger cyclic guanosine monophosphate (cGMP) mediates the physiological effects of nitric oxide and natriuretic peptides in a broad spectrum of tissues and cells. So far, the major focus of research on cGMP lay on the cardiovascular system.
Alexander, Pfeifer, Ana, Kilić, Linda Sarah, Hoffmann   +2 more
openaire   +2 more sources